Aequus Pharmaceuticals Inc. (AQSZF)
OTCMKTS · Delayed Price · Currency is USD
0.0034
0.00 (0.00%)
At close: Sep 5, 2025
Aequus Pharmaceuticals Market Cap
Aequus Pharmaceuticals has a market cap or net worth of $478.54 thousand as of September 12, 2025. Its market cap has decreased by -83.73% in one year.
Market Cap
478.54K
Enterprise Value
5.21M
Revenue
597.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 18, 2015, Aequus Pharmaceuticals's market cap has decreased from 14.25M to 478.54K, a decrease of -96.64%. That is a compound annual growth rate of -28.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 478.54K | -48.09% |
| Dec 31, 2024 | 921.81K | -63.30% |
| Dec 27, 2023 | 2.51M | -26.77% |
| Dec 30, 2022 | 3.43M | -71.54% |
| Dec 31, 2021 | 12.05M | 14.36% |
| Dec 31, 2020 | 10.54M | 35.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Elite Pharmaceuticals | 736.80M |
| Tian'an Technology Group | 732.84M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 346.29M |